VERU · Veru Inc. · Metrics
$2.50
+0.02 (+0.83%)
At close · Sep 10
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These uncertainties raise substantial doubt regarding our ability to continue as a going concern for a period of twelve months subsequent to the issuance date of the financial statements included in this report. Certain elements of our operating plan to alleviate the conditions that raise substantial doubt, including but not limited to our ability to secure equity financing or other financing alternatives, are outside of our control and cannot be included in management's evaluation under the requirements of ASC 205-40, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern. Accordingly, we have concluded that substantial doubt exists about our ability to continue as a going concern for a period of at least twelve months subsequent to the issuance date of the financial statements included in this report.”View the 10-Q filed Aug 10, 2026
Market Cap
$42.28M
Shares
17.05M
VERU metrics
63 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$2.48
Market cap
$42.28M
Price action
20 metricsPrice change (1W)
-4.1%
Price change (30D)
-6.9%
Price change (3M)
-16.8%
Price change (6M)
+4.5%
Price change (YTD)
+20.6%
Price change (1Y)
-23.4%
Trailing year
Price change (5Y)
—
52-week high
$4.43
52-week low
$2.09
Change from 52-week high
-41.8%
Change from 52-week low
+23.4%
Annualized volatility
111.4%
Annualized volatility (3M)
71.1%
Beta
2.3
RSI (14D)
47.8
Price vs SMA 50
-0.1%
Price vs SMA 200
+3.6%
Avg volume (3M)
354,219
Relative volume
3.8
Average dollar volume
$985,986
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
17.05M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.6
reciprocal yield 63.0%
FCF yield
-57.9%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-30.2%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-10
Profitability
9 metricsGross margin
34.7%
Operating margin
-214.2%
Trailing 12 months
Net margin
-223.9%
Gross profit (TTM)
$5.85M
Operating profit (TTM)
−$19.19M
Net income (TTM)
−$13.61M
Trailing 12 months
Diluted EPS (TTM)
$-3.50
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+81.1%
Year over year · more shares
Revenue CAGR (3Y)
-34.9%
Revenue CAGR (5Y)
-11.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-48.0%
Return on assets
-36.8%
Debt / equity
—
Current ratio
4.4
EBITDA (TTM)
−$19.08M
Free cash flow (TTM)
−$26.04M
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$23.88M
Total assets
$37.03M
Total debt
$1.70M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$26.04M
Capital expenditures (TTM)
$0
R&D (TTM)
$11.76M
SG&A (TTM)
$28.22M
Stock compensation (TTM)
$3.27M
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
63
13F filer change QoQ
+3
Institutional ownership
20.6%
Short interest
3 metricsShort interest
8.2%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
62 / 100
Insider activity
2 metricsNet insider buying (90D)
$4,842
Insider-sentiment score
75 / 100
Risk flags
1 metricsGoing concern
Flagged
Key facts
CIK
863894
CUSIP
92536C202
13F (30d)
41 filings
41 filers
Visit website
Investor relations